|
C21ORF45 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.914800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.796400E-01 |
| Normal-vs-Stage2 |
7.356400E-01 |
| Normal-vs-Stage3 |
9.996600E-01 |
| Normal-vs-Stage4 |
8.422200E-01 |
| Stage1-vs-Stage2 |
6.836400E-01 |
| Stage1-vs-Stage3 |
9.800800E-01 |
| Stage1-vs-Stage4 |
8.329400E-01 |
| Stage2-vs-Stage3 |
7.213000E-01 |
| Stage2-vs-Stage4 |
6.602800E-01 |
| Stage3-vs-Stage4 |
8.343800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.551200E-01 |
| Normal-vs-AfricanAmerican |
9.656200E-01 |
| Normal-vs-Asian |
7.282400E-01 |
| Caucasian-vs-AfricanAmerican |
7.898200E-01 |
| Caucasian-vs-Asian |
4.208800E-01 |
| AfricanAmerican-vs-Asian |
8.845200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.623400E-01 |
| Normal-vs-Female |
8.782000E-01 |
| Male-vs-Female |
5.955600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.787000E-01 |
| Normal-vs-Age(41-60Yrs) |
8.774200E-01 |
| Normal-vs-Age(61-80Yrs) |
9.208000E-01 |
| Normal-vs-Age(81-100Yrs) |
9.871000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.423600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.320400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.772600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.067800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.724000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.561600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.735600E-01 |
| Classical-VS-Follicular |
1.159970E-03 |
| Classical-VS-Other |
7.014000E-01 |
| Classical-VS-Normal |
2.759000E-01 |
| Tall-VS-Follicular |
7.379700E-03 |
| Tall-VS-Other |
8.724600E-01 |
| Tall-VS-Normal |
2.471400E-01 |
| Follicular-VS-Other |
1.868980E-01 |
| Follicular-VS-Normal |
4.803700E-02 |
| Other-VS-Normal |
5.972200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.505000E-01 |
| Normal-vs-N1 |
5.590600E-01 |
| N0-vs-N1 |
9.048000E-01 |
|
|
